Alphatec HoldingsATEC
About: Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.
Employees: 839
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
40% more repeat investments, than reductions
Existing positions increased: 88 | Existing positions reduced: 63
34% more call options, than puts
Call options by funds: $3.42M | Put options by funds: $2.55M
2.11% less ownership
Funds ownership: 69.53% [Q1] → 67.42% (-2.11%) [Q2]
3% less funds holding
Funds holding: 222 [Q1] → 216 (-6) [Q2]
15% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 40
26% less capital invested
Capital invested by funds: $1.32B [Q1] → $986M (-$338M) [Q2]
75% less funds holding in top 10
Funds holding in top 10: 4 [Q1] → 1 (-3) [Q2]
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
5 analyst ratings
Needham David Saxon 31% 1-year accuracy 19 / 61 met price target | 40%upside $13 | Buy Reiterated | 31 Oct 2024 |
HC Wainwright & Co. Sean Lee 53% 1-year accuracy 10 / 19 met price target | 116%upside $20 | Buy Reiterated | 31 Oct 2024 |
Lake Street Brooks O'Neil 63% 1-year accuracy 5 / 8 met price target | 94%upside $18 | Buy Maintained | 3 Sept 2024 |
Canaccord Genuity Caitlin Cronin 50% 1-year accuracy 6 / 12 met price target | 116%upside $20 | Buy Maintained | 30 Aug 2024 |
Needham David Saxon 31% 1-year accuracy 19 / 61 met price target | 40%upside $13 | Buy Maintained | 22 Aug 2024 |
Financial journalist opinion
Based on 4 articles about ATEC published over the past 30 days